⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3199574 | 1.00 | — | — | |
| SCHEMBL15088781 | 1.00 | — | — | |
| SCHEMBL3217943 | 1.00 | — | — | |
| SCHEMBL5220310 | 0.68 | — | — | |
| SCHEMBL9602536 | 0.67 | KDM4E (0.32) | — | |
| SCHEMBL22806674 | 0.67 | — | — | |
| SCHEMBL21538186 | 0.67 | — | — | |
| SCHEMBL16772245 | 0.65 | — | — | |
| SCHEMBL893989 | 0.65 | — | — | |
| SCHEMBL25162190 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1074 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3597184-B1 | INDANONE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS OR OPTICAL ISOMERS THEREOF, PREPARATION METHOD FOR SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING VIRAL DISEASES | KOREA RES INST CHEMICAL TECH (KR) | 2026-03-04 | — | — | EP | claimed |
| US-20260048059-A1 | USE OF SUBSTITUTED BENZOXAZOLE AND BENZOFURAN COMPOUNDS FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANC | WIRTH KLAUS (DE) | 2026-02-19 | — | — | US | claimed |
| EP-4572766-A1 | USE OF SUBSTITUTED BENZOXAZOLE AND BENZOFURAN COMPOUNDS FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE | Mitodicure GmbH (DE) | 2025-06-25 | — | — | EP | claimed |
| CN-120040445-A | Heterocyclopyridine-7-one compound and medical application thereof | 浙江大学金华研究院 | 2025-05-27 | — | — | CN | claimed |
| CN-116354923-B | Nitrogen-containing heterocyclic compound and application thereof | 江苏恩华药业股份有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119744345-A | Compositions and methods for single well multiple calibration and compensation | 弹弓生物科学公司 | 2025-04-01 | — | — | CN | claimed |
| WO-2025049569-A2 | EXTENDED PURINE TRICYCLIC AND BICYCLIC NUCLEOSIDES AND NUCLEOTIDES FOR USE AS ANTIVIRAL THERAPEUTICS | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2025-03-06 | — | — | WO | claimed |
| WO-2024222807-A1 | NOVEL MACROCYCLIC HETEROARYL DERIVATIVES AS KINASE INHIBITORS | HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO., LTD (CN) | 2024-10-31 | — | — | WO | claimed |
| CN-114008066-B | Method for producing peptide or protein or peptidomimetic | 斯特兰化学公司 | 2024-10-29 | — | — | CN | claimed |
| CN-118604204-A | Qualitative detection method for blood-entering component and liver-entering component of rabdosia rubescens | 广西中医药大学 | 2024-09-06 | — | — | CN | claimed |
| EP-3658109-B1 | COOLING AND FLAVOR BOOSTING COMPOSITIONS | FIRMENICH & CIE (CH) | 2022-12-07 | — | — | EP | claimed |
| EP-4081521-A1 | SUBSTITUTED TRICYCLIC COMPOUNDS | Lupin Limited (IN) | 2022-11-02 | — | — | EP | claimed |
| EP-4065230-A1 | THERAPEUTIC COMPOUNDS | Genentech, Inc. (US) | 2022-10-05 | — | — | EP | claimed |
| WO-2022093850-A1 | ISOXAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2022-05-05 | — | — | WO | claimed |
| EP-3983074-A1 | PYRIDINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | Janssen Pharmaceutica NV (BE) | 2022-04-20 | — | — | EP | claimed |
| CN-114306550-A | Traditional Chinese medicine formula for regulating and controlling intestinal function of perimenopausal women | 刘敏如女科医系研究院(深圳)有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-114245753-A | Combination of an anti-HER 2 antibody and a CDK inhibitor for tumor therapy | 江苏康宁杰瑞生物制药有限公司 | 2022-03-25 | — | — | CN | claimed |
| WO-2022049146-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | SYNGENTA CROP PROTECTION AG (CH) | 2022-03-10 | — | — | WO | claimed |
| US-11235332-B2 | Accelerated hydrolysis system | ETHICON, INC. (US) | 2022-02-01 | — | — | US | claimed |
| CN-113968890-A | Preparation method of plant source 7-ketolithocholic acid isomer impurity | 湖南科瑞生物制药股份有限公司 | 2022-01-25 | — | — | CN | claimed |